Will 2022 Be Medtech's Biggest Year for M&A?

Will 2022 be the year of medtech M&A. EY’s John Babitt joins us to talk about acquisition trends and deal-making activity in the latest episode of Let’s Talk Medtech.

Omar Ford

January 27, 2022

1 Min Read
John Babitt EY.jpg
Image Courtesy of EY

Medtech M&A took off in 2021 and if there’s any indication to the recent earnings reports that came out, 2022 could be an even bigger year.  John Babitt, a Life Science Partner with EY joins us for this episode of Let’s Talk Medtech for a candid conversation regarding M&A.

Babitt speaks on trends reported in EY’s Annual M&A Firepower Report. Click here for a transcript of the first 1,000 words of Let’s Talk Medtech’s conversation with John Babitt, and check below for the full episode.

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like